Navigation Links
Tiny fish make 'eyes' at their killer
Date:8/19/2013

Small prey fish can grow a bigger 'eye' on their rear fins as a way of distracting predators and dramatically boosting their chances of survival, new scientific research has found.

Researchers from Australia's ARC Centre of Excellence for Coral Reef Studies (CoECRS) have made a world-first discovery that, when constantly threatened with being eaten, small damsel fish not only grow a larger false 'eye spot' near their tail but also reduce the size of their real eyes.

The result is a fish that looks like it is heading in the opposite direction potentially confusing predatory fish with plans to gobble them up, says Oona Lnnstedt, a graduate student at CoECRS and James Cook University.

For decades scientists have debated whether false eyespots, or dark circular marks on less vulnerable regions of the bodies of prey animals, played an important role in protecting them from predators or were simply a fortuitous evolutionary accident.

The CoECRS team has found the first clear evidence that fish can change the size of both the misleading spot and their real eye to maximise their chances of survival when under threat.

"It's an amazing feat of cunning for a tiny fish," Ms Lonnstedt says. "Young damsel fish are pale yellow in colour and have this distinctive black circular 'eye' marking towards their tail, which fades as they mature. We figured it must serve an important purpose when they are young."

"We found that when young damsel fish were placed in a specially built tank where they could see and smell predatory fish without being attacked, they automatically began to grow a bigger eye spot, and their real eye became relatively smaller, compared with damsels exposed only to herbivorous fish, or isolated ones.

"We believe this is the first study to document predator-induced changes in the size of eyes and eye-spots in prey animals."

When the researchers investigated what happens in nature on a c
'/>"/>

Contact: Oona Lonnstedt
oona.lonnstedt1@jcu.edu.au
64-670-021-8346
ARC Centre of Excellence in Coral Reef Studies
Source:Eurekalert

Page: 1 2

Related biology news :

1. MIT researchers reveal how the brain keeps eyes on the prize
2. TabletKiosk and SMI Collaborate to Produce the Sahara EyeSlate
3. Pleasure response from chocolate: You can see it in the eyes
4. Zebrafish may hold the answer to repairing damaged retinas and returning eyesight to people
5. Looking into a flys eyes
6. New technique to deliver stem cell therapy may help damaged eyes regain their sight
7. Seeing the world through the eyes of an Orangutan
8. Brain may see more than the eyes, study indicates
9. EyeLock Inc. Introduces EyeSwipe Nano TS Iris Scanning Turnstile Solution for Secure Access Control
10. The eyes have it: Men do see things differently to women
11. Color-coded markers may help doctors diagnose neural diseases through the eyes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2015)... , Aug. 19, 2015  VOXX International Corporation ... has entered into a Definitive Agreement to purchase ... iris authentication market leader EyeLock through an acquiring ... have a controlling interest in the acquiring entity. ... completion of due diligence.  Expanding on its existing ...
(Date:8/12/2015)... As the digital payment services ... advanced biometrics technology is accelerating beyond expectations.  While the ... using their credit cards, the digital currency, mobile payment ... services led by companies in the space such as ... (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ...
(Date:8/10/2015)... , August 10, 2015 The latest ... offers comprehensive analysis of the global border security market ... revenues of $16.4bn in 2015. Now: Border security ... an example of the business critical issue you need to ... visiongain ,s objective analysis of how this will impact ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
... California pistachios took center stage at this year,s American ... (FNCE), the industry,s premier conference where thousands of registered ... emerging health trends. Pistachios led with ... of mindful eating and, for the first time ever, ...
... A monoclonal antibody targeting a well known cell surface ... aggressive form of the disease that did not respond ... with the UCLA Department of Urology and UCLA,s Jonsson ... the protein, N-cadherin, is up regulated or turned on ...
... found that women who receive silicone implants after a double ... receive saline implants. Published early online in CANCER , ... may help physicians and breast cancer survivors as they together ... have one or both of their breasts removed as a ...
Cached Biology News:California pistachios: Dietitian and Mother Nature approved 2California pistachios: Dietitian and Mother Nature approved 3UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 2UCLA researchers discover a potential target for therapy for patients with a deadly prostate cancer 3Breast cancer patients prefer silicone over saline implants after mastectomy 2
(Date:9/2/2015)... ... September 02, 2015 , ... ... to creating professional commercial video content, to analysis of athletic performance. Producing ... that go by too quickly to process with the naked eye. , ...
(Date:9/1/2015)... , Sept. 1, 2015 The American ... Intent (LOI) for its Discovery Research Grant program. LOIs ... at 12:00 noon CDT. Discovery Grants ... with the potential to change current diagnostic or treatment ... grants specifically encourage novel research at its earliest stages, ...
(Date:9/1/2015)... ... ... In her thought provoking debut novel ‘ Ebola Vaccine Wars ’ (eBookIt.com; ... an Ebola pandemic that is on the cusp of wiping out humanity. Venice introduces ... counterterrorism, and who continues to appear in this series of books by Venice. ...
(Date:9/1/2015)... MA (PRWEB) , ... September 01, 2015 , ... ... top biopharmaceutical companies in the neuro and pain management space join prominent academics ... B. Martin Conference Center at Harvard Medical School in Boston. , Neuro ...
Breaking Biology Technology:Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3American Brain Tumor Association Seeks Innovative Concepts For Discovery Research Grants 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3Neuro Advance Boston Brings Together Leading Neuroscience Experts on October 14 at Harvard Medical School 2
... Permitted to Enroll in 2nd and 3rd ... Eliminated, SAN DIEGO, Dec. 13 Arena ... initiation of patient screening in,the second and third ... of its lead drug candidate, lorcaserin hydrochloride, for ...
... Dec. 13 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI; ... for infectious,diseases, reports financial results for the ... update on its programs., UPDATE ON ... (Omigard(TM)/CPI-226/MX-226; topical cationic peptide;,prevention of catheter-related infections): ...
... Announced Details of a Planned Phase II Study of ... Relapsing Remitting Multiple Sclerosis, COPENHAGEN, Denmark, December 13 ... planned Phase II study of,ofatumumab (HuMax-CD20(R)) for the treatment ... be enrolled in,the study which will be conducted under ...
Cached Biology Technology:Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 2Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 3Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 4Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 5Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity 6MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 2MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 3MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 4MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 5MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 6MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 7MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 8MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 9MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 10MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 11MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 12MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 13MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 14MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 15MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 16MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 17MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results 18Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 2Genmab Announces Details of Planned Ofatumumab Phase II Study in Multiple Sclerosis 3
... Hybaid's unique Electro-4 design allows "4 gels ... it is possible to run 200,samples or ... stacking up to four,horizontal gels. To ensure ... to the number of gels being run. ...
... Continuing a tradition of progressive centrifuge design ... series. The Centra-CL3 and Centra-CL3R (refrigerated) general ... laboratory., Quality Control Over Sample Preparation ... lock up to 99 protocols and has ...
... DNA Polymerase I Large (Klenow) Fragment, Exonuclease ... lacks both the 5´→3´ and the 3´→5´ ... DNA Polymerase I (1,2). It is used ... strand displacement amplification (5). Klenow Fragment, Exonuclease ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
Biology Products: